behold.ai, a London-based imaging technology company, has received FDA clearance for its AI algorithm designed to help radiologists triage pneumothorax patients.

The new coronavirus could infect between 70 million and 150 million people in the U.S., according to the attending physician of Congress and the Supreme Court, Brian Monahan. 

AI’s impact on healthcare continues to grow, with specialties such as radiology and cardiology fully embracing the technology’s potential to modify workflows and improve patient outcomes. Family medicine physicians, however, have been slow to embrace this growing trend.

The American College of Radiology Data Science Institute (ACR DSI) has shared an AI use case for the new coronavirus, publishing it just as the World Health Organization declared COVID-19 a pandemic.

RadNet, one of the largest radiology providers in the United States, has entered into a definitive agreement to acquire DeepHealth, an imaging technology company focused on using AI to improve breast cancer screening.  

Researchers are using advanced technology—including AI, natural language processing (NLP) and satellite imaging—to track how the new coronavirus has impacted China.

Researchers still don’t truly understand how these algorithms work—and that’s a significant issue.

DeepMind, a London-based AI company acquired by Google back in 2014, is sharing predictions made by its advanced AlphaFold system that could help researchers learn more about the new coronavirus.